Ben E.E.M. van den Borne

2.9k citations

29 papers · 977 indexed · h-index 16

Pulmonary and Respiratory Medicine top 5%
Oncology top 10%
Surgery
Orthopedics and Sports Medicine top 5%
Physiology

Co-authors: Martijn A. Spruit Frank W.J.M. Smeenk Emiel F.�M. Wouters Lidwien Graat‐Verboom Ragnar Lunde Harry J.M. Groen Bonne Biesma J. J. Jakimowicz
Topics: Lung Cancer Research Studies (12 papers)Lung Cancer Treatments and Mutations (12 papers)Lung Cancer Diagnosis and Treatment (6 papers)
Cited by: Orthopedics and Sports Medicine Pulmonary and Respiratory Medicine Oncology
Journals: Journal of Clinical Oncology Annals of Oncology European Respiratory Journal
Partner nations: Netherlands United States Italy

In The Last Decade

Ben E.E.M. van den Borne

27 papers receiving 937 citations

Peers

Countries citing papers authored by Ben E.E.M. van den Borne

Since Specialization

Citations

This map shows the geographic impact of Ben E.E.M. van den Borne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ben E.E.M. van den Borne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ben E.E.M. van den Borne more than expected).

Fields of papers citing papers by Ben E.E.M. van den Borne

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ben E.E.M. van den Borne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ben E.E.M. van den Borne. The network helps show where Ben E.E.M. van den Borne may publish in the future.

Co-authorship network of co-authors of Ben E.E.M. van den Borne

This figure shows the co-authorship network connecting the top 25 collaborators of Ben E.E.M. van den Borne. A scholar is included among the top collaborators of Ben E.E.M. van den Borne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ben E.E.M. van den Borne. Ben E.E.M. van den Borne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Impact of Immune Checkpoint Inhibitors and Local Radical Treatment on Survival Outcomes in Synchronous Oligometastatic NSCLC 2025 ·JTO Clinical and Research Reports ·(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Juliette Degens,Ben E.E.M. van den Borne,(unknown),(unknown),Cordula Pitz,Dirk K.M. De Ruysscher,Lizza Hendriks	0
2	The Toxicity Profile of Pemetrexed in Non-Small Cell Lung Cancer Patients With Moderate Renal Impairment: A Retrospective Cohort Study 2025 ·Clinical Lung Cancer ·(unknown),Rob ter Heine,(unknown),(unknown),(unknown),Bas Peters,Nienke A. G. Lankheet,(unknown),(unknown),Eric J. F. Franssen,(unknown),Cor H. van der Leest,(unknown),(unknown),(unknown),John W.G. van Putten,Ben E.E.M. van den Borne,Michel M. van den Heuvel,Maarten J. Deenen	0
3	Opportunities for Precision Dosing of Cytotoxic Drugs in Non-Small Cell Lung Cancer: Bridging the Gap in Precision Medicine 2025 ·Clinical Pharmacokinetics ·(unknown),Maarten J. Deenen,Anthonie J. van der Wekken,Ben E.E.M. van den Borne,Michel M. van den Heuvel,Rob ter Heine	3
4	An Evidence-Based Rationale for Dose De-escalation of Subcutaneous Atezolizumab 2024 ·Targeted Oncology ·(unknown),Maarten J. Deenen,Dirk Jan A. R. Moes,Jeroen J. M. A. Hendrikx,Ben E.E.M. van den Borne,Daphne W. Dumoulin,Anthonie J. van der Wekken,(unknown),Rob ter Heine	2
5	Open communication between patients and relatives about illness & death in advanced cancer—results of the eQuiPe Study 2024 ·Supportive Care in Cancer ·(unknown),(unknown),Linda Brom,Arnold Baars,Jean‐Paul van Basten,Ben E.E.M. van den Borne,Mathijs P. Hendriks,Wouter K. de Jong,Hanneke W.M. van Laarhoven,Anne S. R. van Lindert,Caroline M.P.W. Mandigers,(unknown),Tineke J. Smilde,(unknown),Liesbeth M. van Vliet,Natasja Raijmakers	3
6	Strengths and challenges in current lung cancer care: Timeliness and diagnostic procedures in six Dutch hospitals 2024 ·Lung Cancer ·(unknown),(unknown),(unknown),Huub Belderbos,Gerben Stege,(unknown),(unknown),Luc Brunsveld,Maarten A.C. Broeren,Daan van de Kerkhof,Federica Eduati,Ben E.E.M. van den Borne,Volkher Scharnhorst	2
7	Liquid biopsy-based decision support algorithms for diagnosis and subtyping of lung cancer 2023 ·Lung Cancer ·(unknown),(unknown),(unknown),Ben E.E.M. van den Borne,(unknown),Huub Belderbos,Gerben Stege,(unknown),(unknown),Luc Brunsveld,Maarten A.C. Broeren,Daan van de Kerkhof,Birgit Deiman,Federica Eduati,Volkher Scharnhorst	21
8	The association of body mass index with safety and effectiveness of first-line carboplatin-based chemotherapy in patients with metastatic non-small cell lung cancer 2022 ·Cancer Treatment and Research Communications ·(unknown),(unknown),(unknown),Saskia Houterman,Ben E.E.M. van den Borne,Annet Smit,E.M.W. van de Garde,Maarten J. Deenen	2
9	Randomised controlled trial of first-line tyrosine-kinase inhibitor (TKI)versusintercalated TKI with chemotherapy forEGFR-mutated nonsmall cell lung cancer 2022 ·ERJ Open Research ·(unknown),Vincent van der Noort,Joachim G.J.V. Aerts,(unknown),Egbert F. Smit,Frans H. Krouwels,(unknown),T. Jeroen N. Hiltermann,Wim Timens,Ed Schuuring,(unknown),(unknown),(unknown),Adrianus J. de Langen,Jos A. Stigt,Ben E.E.M. van den Borne,Harry J.M. Groen,Wouter H. van Geffen,Anthonie J. van der Wekken	10
10	Utilization of Molecular Testing and Survival Outcomes of Treatment with First- or Second-line Tyrosine Kinase Inhibitors in Advanced Non-small Cell Lung Cancer in a Dutch Population 2018 ·Anticancer Research ·(unknown),Ben E.E.M. van den Borne,Paul Roepman,Bas Peters,Elisabeth A. Kastelijn,Franz M.N.H. Schramel	14
11	A randomized phase II study comparing paclitaxel–carboplatin–bevacizumab with or without nitroglycerin patches in patients with stage IV nonsquamous nonsmall-cell lung cancer: NVALT12 (NCT01171170) 2015 ·Annals of Oncology ·Anne‐Marie C. Dingemans,Harry J.M. Groen,Gerarda J.M. Herder,Jos A. Stigt,Egbert F. Smit,Idris Bahce,J.A. Burgers,Ben E.E.M. van den Borne,Bonne Biesma,Andrew Vincent,Vincent van der Noort,(unknown)	30
12	Patient reported outcomes following stereotactic ablative radiotherapy or surgery for stage IA non-small-cell lung cancer: Results from the ROSEL multicenter randomized trial 2015 ·Radiotherapy and Oncology ·Alexander V. Louie,Erik van Werkhoven,Hanbo Chen,Egbert F. Smit,Marinus A. Paul,Joachim Widder,Harry J.M. Groen,Ben E.E.M. van den Borne,Katrien De Jaeger,Ben J. Slotman,Suresh Senan	59
13	Patient selection for whole brain radiotherapy (WBRT) in a large lung cancer cohort: Impact of a new Dutch guideline on brain metastases 2014 ·Acta Oncologica ·Lizza Hendriks,Esther G.C. Troost,(unknown),Gerben Bootsma,Katrien De Jaeger,Ben E.E.M. van den Borne,Anne‐Marie C. Dingemans	14
14	Interobserver Variability for the WHO Classification of Pulmonary Carcinoids 2014 ·The American Journal of Surgical Pathology ·Dorian R.A. Swarts,Robert‐Jan van Suylen,Michael A. den Bakker,Matthijs F.M. van Oosterhout,Erik Thunnissen,Marco Volante,Anne‐Marie C. Dingemans,Marc R. Scheltinga,Gerben Bootsma,(unknown),Ben E.E.M. van den Borne,Frans C. S. Ramaekers,Ernst‐Jan M. Speel	67
15	Risk factors for osteoporosis in Caucasian patients with moderate chronic obstructive pulmonary disease: A case control study 2012 ·Bone ·Lidwien Graat‐Verboom,Frank W.J.M. Smeenk,Ben E.E.M. van den Borne,Martijn A. Spruit,(unknown),(unknown),Emiel F.�M. Wouters	45
16	Cardiac herniation after operative management of lung cancer: a rare and dangerous complication 2012 ·General Thoracic and Cardiovascular Surgery ·Jeroen E. H. Ponten,Ted Elenbaas,Joost F. ter Woorst,(unknown),Ben E.E.M. van den Borne,Albert H.M. van Straten	9
17	Correlates of osteoporosis in chronic obstructive pulmonary disease: An underestimated systemic component 2009 ·Respiratory Medicine ·Lidwien Graat‐Verboom,Martijn A. Spruit,Ben E.E.M. van den Borne,Frank W.J.M. Smeenk,Elisabeth J. Martens,Ragnar Lunde,Emiel F.�M. Wouters	88
18	Negligible influence of comorbidity on prognosis of patients with small cell lung cancer: A population-based study in the Netherlands 2007 ·Critical Reviews in Oncology/Hematology ·M.L.G. Janssen‐Heijnen,V.E.P.P. Lemmens,Ben E.E.M. van den Borne,Bonne Biesma,S.B. Oei,J.W.W. Coebergh	34
19	Intravenous ATP infusions can be safely administered in the home setting: a study in pre-terminal cancer patients 2007 ·Investigational New Drugs ·Sandra Beijer,(unknown),P. Hupperets,Ben E.E.M. van den Borne,M.H.J. van den Beuken-van Everdingen,Marten R. Nijziel,(unknown),Pieter C. Dagnelie	23
20	Segmental spinal anaesthesia for cholecystectomy in a patient with severe lung disease 2006 ·British Journal of Anaesthesia ·André van Zundert,G.N. Stultiëns,J. J. Jakimowicz,Ben E.E.M. van den Borne,(unknown),J.A.W. Wildsmith	85

About Ben E.E.M. van den Borne

Ben E.E.M. van den Borne is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Orthopedics and Sports Medicine, having authored 29 papers that have together received 977 indexed citations. Recurring topics across this work include Lung Cancer Research Studies (12 papers), Lung Cancer Treatments and Mutations (12 papers) and Lung Cancer Diagnosis and Treatment (6 papers). The work is most often cited by research in Orthopedics and Sports Medicine (190 citations), Pulmonary and Respiratory Medicine (529 citations) and Oncology (247 citations). Ben E.E.M. van den Borne has collaborated with scholars based in Netherlands, United States and Italy. Frequent co-authors include Martijn A. Spruit, Frank W.J.M. Smeenk, Emiel F.�M. Wouters, Lidwien Graat‐Verboom, Ragnar Lunde, Harry J.M. Groen, Bonne Biesma, J. J. Jakimowicz, J.A.W. Wildsmith and G.N. Stultiëns. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology and European Respiratory Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact